• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[经皮腔内室间隔心肌消融术治疗肥厚性梗阻性心肌病]

[Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy].

作者信息

Qiao Shu-bin, Gao Run-lin, You Shi-jie, Yuan Jian-song, Chen Ji-lin, Yang Yue-jin

机构信息

Department of Cardiology, Cardiovascular Institute and Fuwai Hospital, Chinese Academy of Medical Science, Peking Union Medical College, Beijing 100037, China.

出版信息

Zhonghua Nei Ke Za Zhi. 2006 Mar;45(3):210-2.

PMID:16624154
Abstract

OBJECTIVE

Gauging the acute effect of Percutaneous transluminal septal myocardial ablation (PTSMA) as a treatment for hypertrophic obstructive cardiomyopathy (HOCM).

METHODS

PTSMA was performed in 52 patients with symptomatic HOCM [mean age (44.7 +/- 11.9), male 38, female 14]. All patients had echocardiography performed prior to the procedure, 3-7 days post-PTSMA.

RESULTS

Procedure success was achieved in 41 patients, success rate was 78.8%. The average left ventricular outflow tract (LVOT) gradient was (92.64 +/- 38.69) mm Hg before the procedure, and (51.79 +/- 38.99) mm Hg after the procedure (P < 0.001). The thickness of interventricular septum (IVS) was (22.96 +/- 5.15) mm before the procedure and became (21.27 +/- 4.64) mm 3-7 days post-PTSMA (P < 0.05). The incidence of right bundle branch block development post-PTSMA was 15.38% (> 48 h), and one patient (1.92%) had complete heart block. Two patients died.

CONCLUSION

PTSMA is an effective non-surgical procedure for symptomatic patients with HOCM because of its low risk and its significant hemodynamic and echocardiographic improvement.

摘要

目的

评估经皮腔内室间隔心肌消融术(PTSMA)治疗肥厚型梗阻性心肌病(HOCM)的急性效果。

方法

对52例有症状的HOCM患者[平均年龄(44.7±11.9)岁,男性38例,女性14例]实施PTSMA。所有患者在术前、PTSMA术后3 - 7天均接受了超声心动图检查。

结果

41例患者手术成功,成功率为78.8%。术前平均左心室流出道(LVOT)压差为(92.64±38.69)mmHg,术后为(51.79±38.99)mmHg(P<0.001)。术前室间隔(IVS)厚度为(22.96±5.15)mm,PTSMA术后3 - 7天变为(21.27±4.64)mm(P<0.05)。PTSMA术后右束支传导阻滞发生率为15.38%(>48小时),1例患者(1.92%)发生完全性心脏传导阻滞。2例患者死亡。

结论

PTSMA对有症状的HOCM患者是一种有效的非手术治疗方法,因其风险低且能显著改善血流动力学和超声心动图表现。

相似文献

1
[Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy].[经皮腔内室间隔心肌消融术治疗肥厚性梗阻性心肌病]
Zhonghua Nei Ke Za Zhi. 2006 Mar;45(3):210-2.
2
Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy; The Chinese experience in 119 patients from a single center.经皮腔内室间隔心肌消融术治疗肥厚型梗阻性心肌病:来自单一中心119例患者的中国经验
Int J Cardiol. 2004 Feb;93(2-3):197-202. doi: 10.1016/j.ijcard.2003.03.005.
3
Comparison of percutaneous transluminal septal myocardial ablation versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy--a meta analysis.经皮腔内室间隔心肌消融术与室间隔心肌切除术治疗肥厚性梗阻性心肌病患者的比较——一项荟萃分析
Int J Cardiol. 2006 Sep 10;112(1):80-4. doi: 10.1016/j.ijcard.2005.10.009. Epub 2006 Feb 28.
4
Early remodelling of left ventricle and improvement of myocardial performance in patients after percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy.肥厚性梗阻性心肌病患者经皮腔内室间隔心肌消融术后左心室的早期重塑及心肌性能改善
Int J Cardiol. 2003 Mar;88(1):27-32. doi: 10.1016/s0167-5273(02)00381-9.
5
Successful percutaneous transluminal septal myocardial ablation through a right superior septal artery for a patient with hypertrophic obstructive cardiomyopathy.通过右上间隔动脉对肥厚型梗阻性心肌病患者成功进行经皮腔内间隔心肌消融术。
Cardiovasc Interv Ther. 2015 Oct;30(4):377-81. doi: 10.1007/s12928-014-0310-4. Epub 2014 Dec 13.
6
Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients.经皮腔内室间隔心肌消融术治疗肥厚型梗阻性心肌病:25例患者的急性结果及3个月随访
J Am Coll Cardiol. 1998 Feb;31(2):252-8. doi: 10.1016/s0735-1097(97)00508-1.
7
Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Acute results and three-year noninvasive follow-up in 18 patients.经皮腔内室间隔心肌消融术治疗肥厚性梗阻性心肌病:18例患者的急性结果及三年无创随访
Can J Cardiol. 2004 Jun;20(8):779-82.
8
[Non-pharmacologic therapy of hypertrophic obstructive cardiomyopathy--results of therapy based on percutaneous transluminal septal myocardial ablation compared with results of dual-chamber cardiac pacing].肥厚性梗阻性心肌病的非药物治疗——经皮腔内室间隔心肌消融术治疗结果与双腔心脏起搏治疗结果的对比
Vnitr Lek. 2006 Apr;52(4):313-20.
9
Percutaneous versus surgical treatment for patients with hypertrophic obstructive cardiomyopathy and enlarged anterior mitral valve leaflets.肥厚性梗阻性心肌病合并二尖瓣前叶增大患者的经皮治疗与手术治疗对比
Circulation. 2005 Jul 26;112(4):482-8. doi: 10.1161/CIRCULATIONAHA.104.508309. Epub 2005 Jul 18.
10
[Percutaneous transluminal septal myocardial ablation: early results and long-term follow-up].[经皮腔内室间隔心肌消融术:早期结果及长期随访]
Przegl Lek. 2006;63(8):628-32.